Vaccines
9 February 2016
Immune Design Announces Positive Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product Candidates28 January 2016
Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial22 January 2016
Takeda Announces New Drug Application Approval in Japan for a Haemophilus influenzae type b conjugate vaccine, “VAXEM Hib®”12 January 2016
SELLAS Life Sciences Announces Preliminary Positive WT1 Cancer Vaccine Clinical Results in Multiple Myeloma Patients12 January 2016
Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine11 January 2016
Aimmune Therapeutics Enrolls First Patient in Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy5 January 2016
AiCuris’ AIC649 Shows Potential to Induce Functional Cure of Chronic Hepatitis B in Preclinical Study4 January 2016
Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant24 December 2015
CMV Vaccine Created at City of Hope is Found Safe, Effective in Patients Receiving Stem Cell Transplants23 December 2015
World Health Organization to Review Merck’s Investigational Ebola Vaccine for Emergency Use Assessment and Listing22 December 2015
Aduro Biotech Announces Initiation of Phase 1 Study of ADU-741 for the Treatment of Prostate Cancer19 December 2015
Saronic Biotechnology Files Investigational New Drug Application With FDA for SBI1997 Phase I/II Clinical Trial17 December 2015
Aduro Biotech Receives Milestone Payment From Janssen for Acceptance of Investigational New Drug Application for ADU-741 in Prostate Cancer16 December 2015
U.S. Food and Drug Administration Accepts Biologics License Application for PaxVax’s Single-Dose Oral Cholera Vaccine Vaxchora16 December 2015
FDA Approves Expanded Age Indication for GARDASIL® 9 in Males10 December 2015
ImmBio Initiates First-in-Human Studies of its Novel Pneumococcal Vaccine, PnuBioVax8 December 2015
DBV Technologies Announces Initiation of Phase III Study of Viaskin(r) Peanut for the Treatment of Peanut Allergic Children6 December 2015
Dynavax Presents Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, at ASH Annual MeetingNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports